TRLS Stock Overview
Provides digital chronic condition management solutions for employers and health plans. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Trellus Health plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.0057 |
| 52 Week High | UK£0.074 |
| 52 Week Low | UK£0.0055 |
| Beta | 0.15 |
| 1 Month Change | -14.81% |
| 3 Month Change | -52.08% |
| 1 Year Change | -82.31% |
| 3 Year Change | -98.66% |
| 5 Year Change | n/a |
| Change since IPO | -99.12% |
Recent News & Updates
Shareholder Returns
| TRLS | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | -8.0% | -0.7% | -1.5% |
| 1Y | -82.3% | -24.7% | 3.5% |
Return vs Industry: TRLS underperformed the UK Healthcare industry which returned -24.7% over the past year.
Return vs Market: TRLS underperformed the UK Market which returned 3.5% over the past year.
Price Volatility
| TRLS volatility | |
|---|---|
| TRLS Average Weekly Movement | 13.7% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: TRLS's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: TRLS's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 31 | Marla Dubinsky | www.trellushealth.com |
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis.
Trellus Health plc Fundamentals Summary
| TRLS fundamental statistics | |
|---|---|
| Market cap | UK£928.67k |
| Earnings (TTM) | -UK£5.32m |
| Revenue (TTM) | UK£43.90k |
21.2x
P/S Ratio-0.2x
P/E RatioIs TRLS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRLS income statement (TTM) | |
|---|---|
| Revenue | US$55.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$55.00k |
| Other Expenses | US$6.72m |
| Earnings | -US$6.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.041 |
| Gross Margin | 100.00% |
| Net Profit Margin | -12,114.55% |
| Debt/Equity Ratio | 0% |
How did TRLS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 23:24 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Trellus Health plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|